Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Intervalo de año de publicación
1.
BMC Infect Dis ; 23(1): 50, 2023 Jan 24.
Artículo en Inglés | MEDLINE | ID: mdl-36694138

RESUMEN

BACKGROUND: Nannizziopsis is a genus of fungi with several known cases in reptiles of pyogranulomatous infections at cutaneous and musculoskeletal level, of rapid and fatal evolution. There are few cases of this genus described in humans, mainly skin affection but also with visceral abcesses, typically in immunosuppressed patients, with a recent visit to Africa. CASE PRESENTATION: A 45-year-old woman immunosuppressed after renal transplantation and with a recent visit to Nigeria presented with a painless breast abcess, ulceration to the skin and bleeding, and non hematic telorrhea. The mammogram, also completed with an ultrasound scan, showed a polylobulated nodule, BI-RADS 4C. Due to the suspicion of breast cancer, a core needle biopsy was performed and the pathology study showed abundant presence of fungal spores and hyphae. It was identified by genomic amplification of the internal transcription spacer region-2 and a percentage of similarity with sequences of Nannizziopsis obscura from GenBank of 98% was obtained. An empiric treatment with anidulafungin was initiated, and after the surgical resection, it was replaced by isavuconazole, with a total time of treatment of one month. CONCLUSIONS: This is the first case report of a successful treatment of Nannizziopsis obscura with isavuconazole, with the shortest time of treatment published for this fungi. We highlighted the importance of referring difficult to diagnose species to reference centers, as well as achieving the most complete resection in order to shorten the antibiotic therapy.


Asunto(s)
Trasplante de Riñón , Femenino , Humanos , Persona de Mediana Edad , Trasplante de Riñón/efectos adversos , Nigeria , Absceso/diagnóstico , Absceso/tratamiento farmacológico , Hongos , Huésped Inmunocomprometido
2.
Med. clín (Ed. impr.) ; 138(9): 397-401, abr. 2012.
Artículo en Español | IBECS | ID: ibc-100043

RESUMEN

La deficiencia de vitamina D, definida como valores de 25-hidroxivitamina D < 20-30 ng/ml, es un problema prevalente en la población general. Además de relacionarse clásicamente con la enfermedad musculoesquelética, el déficit de vitamina D se ha relacionado con enfermedades autoinmunes, cáncer, enfermedades metabólicas y enfermedades cardiovasculares. La hipertensión arterial, como principal factor de riesgo cardiovascular, también se ha relacionado con el déficit de vitamina D, llevando a converger dos grandes problemas de salud prevalentes en la población mundial. Por tanto, este artículo revisa aquellos estudios más importantes que vinculan ambas patologías, los mecanismos descritos que las relacionan y la evidencia actual acerca del efecto que la suplementación de vitamina D podría tener sobre la hipertensión arterial (AU)


Low levels of vitamin D, defined as levels of 25-hydroxyvitamin D < 20-30 ng/ml, is a prevalent problem in the general population. Besides the classic relation with musculoskeletal disease, vitamin D has been also related to autoimmune diseases, cancer, metabolic diseases or cardiovascular diseases. High blood pressure, as the main cardiovascular risk factor, also has been related to vitamin D deficiency, constituting two prevalent worldwide health problems. Therefore, this article reviews the most important studies that combine both pathologies, the biological mechanism that relate them and the current evidence about the effect of vitamin D supplementation on hypertension (AU)


Asunto(s)
Humanos , Hipertensión/fisiopatología , Deficiencia de Vitamina D/complicaciones , Enfermedades Cardiovasculares/prevención & control , Factores de Riesgo , Desmineralización Ósea Patológica/prevención & control , Vitamina D/administración & dosificación
3.
Med Clin (Barc) ; 138(9): 397-401, 2012 Apr 14.
Artículo en Español | MEDLINE | ID: mdl-21703643

RESUMEN

Low levels of vitamin D, defined as levels of 25-hydroxyvitamin D < 20-30 ng/ml, is a prevalent problem in the general population. Besides the classic relation with musculoskeletal disease, vitamin D has been also related to autoimmune diseases, cancer, metabolic diseases or cardiovascular diseases. High blood pressure, as the main cardiovascular risk factor, also has been related to vitamin D deficiency, constituting two prevalent worldwide health problems. Therefore, this article reviews the most important studies that combine both pathologies, the biological mechanism that relate them and the current evidence about the effect of vitamin D supplementation on hypertension.


Asunto(s)
Hipertensión/metabolismo , Deficiencia de Vitamina D/fisiopatología , Vitamina D/fisiología , Animales , Enfermedades Autoinmunes/epidemiología , Biotransformación , Calcio/metabolismo , Enfermedades Cardiovasculares/epidemiología , Comorbilidad , Dieta , Susceptibilidad a Enfermedades , Humanos , Hipertensión/tratamiento farmacológico , Hipertensión/epidemiología , Riñón/metabolismo , Mortalidad , Neoplasias/epidemiología , Fósforo/metabolismo , Estudios Prospectivos , Ratas , Receptores de Calcitriol/deficiencia , Receptores de Calcitriol/fisiología , Luz Solar , Vitamina D/metabolismo , Vitamina D/farmacocinética , Vitamina D/uso terapéutico , Deficiencia de Vitamina D/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA